| Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: a double … J Talvas, G Garrait, N Goncalves-Mendès, J Rouanet, ... Clinical nutrition 34 (5), 810-817, 2015 | 69 | 2015 |
| Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry G Dobos, A De Masson, C Ram‐Wolff, M Beylot‐Barry, A Pham‐Ledard, ... British Journal of Dermatology 184 (6), 1059-1067, 2021 | 48 | 2021 |
| Positive association between location of melanoma, ultraviolet signature, tumor mutational burden, and response to anti–PD-1 therapy L Dousset, F Poizeau, C Robert, S Mansard, L Mortier, C Caumont, ... JCO precision oncology 5, 1821-1829, 2021 | 37 | 2021 |
| Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy J Rouanet, V Benboubker, H Akil, A Hennino, P Auzeloux, S Besse, ... Cancer Immunology, Immunotherapy 69 (10), 2075-2088, 2020 | 27 | 2020 |
| Trichodysplasia spinulosa: a polyomavirus infection specifically targeting follicular keratinocytes in immunocompromised patients J Rouanet, F Aubin, P Gaboriaud, P Berthon, MC Feltkamp, L Bessenay, ... British Journal of Dermatology 174 (3), 629-632, 2016 | 25 | 2016 |
| Radioimmunotherapy in oncology: overview of the last decade clinical trials A Rondon, J Rouanet, F Degoul Cancers 13 (21), 5570, 2021 | 23 | 2021 |
| Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments J Rouanet, M Quintana, P Auzeloux, F Cachin, F Degoul Pharmacology & Therapeutics 224, 107829, 2021 | 16 | 2021 |
| Determination of eumelanin and pheomelanin in melanomas using solid-phase extraction and high performance liquid chromatography–diode array detection (HPLC-DAD) analysis B Rioux, J Rouanet, H Akil, S Besse, E Debiton, B Bouchon, F Degoul, ... Journal of Chromatography B 1113, 60-68, 2019 | 16 | 2019 |
| A case of severe pityriasis rubra pilaris with a dramatic response to apremilast L Pellonnet, F Beltzung, F Franck, J Rouanet, M D’incan European Journal of Dermatology 28, 128-129, 2018 | 15 | 2018 |
| Recent outbreak of chilblain‐like lesions is not directly related to SARS‐CoV‐2 infection J Rouanet, E Lang, F Beltzung, B Evrard, C Henquell, I Joulie, M d'Incan Journal of the European Academy of Dermatology and Venereology 34 (11), e689, 2020 | 14 | 2020 |
| New insight into the role of ANXA1 in melanoma progression: Involvement of stromal expression in dissemination S Delorme, M Privat, N Sonnier, J Rouanet, T Witkowski, M Kossai, ... American Journal of Cancer Research 11 (4), 1600, 2021 | 10 | 2021 |
| Targeted radionuclide therapy decreases melanoma lung invasion by modifying epithelial-mesenchymal transition-like mechanisms H Akil, J Rouanet, C Viallard, S Besse, P Auzeloux, JM Chezal, ... Translational Oncology 12 (11), 1442-1452, 2019 | 6 | 2019 |
| Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol E Thivat, J Rouanet, P Auzeloux, N Sas, E Jouberton, S Levesque, ... BMC cancer 22 (1), 417, 2022 | 5 | 2022 |
| Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma H Akil, M Quintana, JH Raymond, T Billoux, V Benboubker, S Besse, ... Cancers 13 (6), 1421, 2021 | 5 | 2021 |
| Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification G Ungan, AF Lavandier, J Rouanet, C Hordonneau, B Chauveau, ... International Journal of Computer Assisted Radiology and Surgery 17 (10 …, 2022 | 4 | 2022 |
| Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease M Prugnit-Rouanet, S Delaumenie, A Couraud, D Audevard, J Rouanet, ... European Journal of Dermatology 32 (3), 368-372, 2022 | 3 | 2022 |
| CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas M Battistella, LP Zhao, G Dobos, C Ram-Wolff, I Madelaine, JC Bories, ... The Journal of investigative dermatology 143 (7), 1329-1332. e3, 2023 | 2 | 2023 |
| Real-life use of bexarotene for T-cell cutaneous lymphoma management: efficacy and tolerance with low doses J Rouanet, I Joulie, C Lambert, M D’INCAN Acta Dermato-Venereologica 102, 2022 | 2 | 2022 |
| Changements dans l’épidémiologie des lymphomes cutanés primitifs en France: une analyse de 8593 patients du registre du Groupe Français d’Etude des Lymphomes Cutanés (GFELC) G Dobos, A de Masson, C Ram-Wolff, M Beylot-Barry, A Pham-Ledard, ... Annales de Dermatologie et de Vénéréologie 147 (12), A148-A149, 2020 | 2 | 2020 |
| Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study D Balayssac, B Pereira, J Desmard, H Viers, C Barillon, A Osseili, ... European Journal of Cancer Care 2023, 2023 | 1 | 2023 |
